Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 6100 participants.
Also called NCT03635749
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 6,100 participants
- Sponsor
- Registry
-
NCT03635749
-
- Other papers using this trial's data
- CYP2C19 Genotype and Efficacy of Clopidogrel Initiated Between 24 to 72 Hours for Ischemic Stroke
- Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of the INSPIRES Randomized Clinical Trial
- Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial
- Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke: A Randomized Trial
- Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack
- Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis
- Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke
- Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack
- Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke
- Efficacy and Safety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic Stroke Stratified by Glycemic Status
- Efficacy and safety of clopidogrel and aspirin initiated within 72 hours after mild ischemic stroke or high-risk TIA by sex: a prespecified subgroup analysis of the INSPIRES trial
- Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular disease
- Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial
- The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03635749. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-17 (actual); primary completion 2023-01-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
- Acronym
- INSPIRES
- Condition
- Acute Stroke
- Condition
- Transient Ischemic Attack
- Intervention (Drug)
- Intensive antiplatelet
- Intervention (Drug)
- Standard antiplatelet
- Intervention (Drug)
- Immediate high-intensity statin
- Intervention (Drug)
- Delayed high-intensity statin
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Ministry of Science and Technology of the People´s Republic of China
Record details
- Record id
cardio:ct-nct03635749- Content hash
4f92f9d088a5f21ff971827adef65e914901b1d5de187b39e9e98d74da72dd5b